The purpose of the following Management's Discussion and Analysis (MD&A) is to
help facilitate the understanding of significant factors influencing the
quarterly operating results, financial condition, and cash flows of the Company.
Additionally, the MD&A also conveys our expectations of the potential impact of
known trends, events, or uncertainties that may impact future results. MD&A is
provided as a supplement to, and should be read in conjunction with, our Annual
Report on Form 10-K for the year ended December 31, 2019, our financial
statements and the accompanying notes to our financial statements, as well as
the Item 1A. Risk Factors contained herein.


                                       19
--------------------------------------------------------------------------------

Business Overview



We provide total talent management services, including strategic workforce
solutions, contingent staffing, permanent placement and other consultative
services for healthcare clients. We recruit and place highly qualified
healthcare professionals in virtually every specialty and area of expertise. Our
diverse client base includes both clinical and nonclinical settings, servicing
acute care hospitals, physician practice groups, outpatient and ambulatory-care
centers, nursing facilities, both public schools and charter schools,
rehabilitation and sports medicine clinics, government facilities, and homecare.
Through our national staffing teams and network of office locations, we offer
our workforce solutions and we are able to place clinicians on travel and per
diem assignments, local short-term contracts and permanent positions. Our
workforce solutions include managed service programs (MSPs), electronic medical
record (EMR) transition staffing, recruitment process outsourcing (RPO),
internal resource pool (IRP), and other outsourcing and consultative services as
described in Item 1. Business in our Annual Report on Form 10-K for the year
ended December 31, 2019. By utilizing our various solutions, clients are able to
better plan their personnel needs, talent acquisition and management processes,
strategically flex and balance their workforce, access quality healthcare
personnel, and provide continuity of care for improved patient outcomes.

We manage and segment our business based on the nature of the services we offer
to our customers. As a result, in accordance with the Segment Reporting Topic of
the FASB ASC, we report three business segments - Nurse and Allied Staffing,
Physician Staffing, and Search.

? Nurse and Allied Staffing - Nurse and Allied Staffing represented
approximately 89% of our total revenue in the first quarter of 2020. The Nurse
and Allied Staffing segment provides workforce solutions and traditional
staffing, including temporary and permanent placement of travel nurses and
allied professionals, as well as per diem and contract nurses and allied
personnel. We also staff healthcare personnel and substitute teachers in public
and charter schools. We provide flexible workforce solutions to our healthcare
clients through diversified offerings designed to meet their unique needs,
including: MSP, optimal workforce solutions (OWS), EMR, IRP and consulting
services.

? Physician Staffing - Physician Staffing represented approximately 9% of our total revenue in the first quarter of 2020. Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States.



? Search - Search represented approximately 2% of our total revenue in the first
quarter of 2020. Search includes retained and contingent search services for
physicians, healthcare executives, and other healthcare professionals, as well
as RPO.

Summary of Operations

For the quarter ended March 31, 2020, revenue from services increased 8%
year-over-year to $210.1 million, primarily due to a higher volume of travel
nurse staffing, and higher average bill rates. The increase in revenue was
partially offset by revenue declines in our local staffing and education
healthcare services primarily driven by the changing landscape in March from the
COVID-19 pandemic. Profitability in the first quarter was impacted by $0.6
million of restructuring costs, $0.7 million of accelerated amortization expense
in connection with our rebranding initiative, and $0.5 million of costs incurred
related to our applicant tracking system replacement. Net loss attributable to
common shareholders was $2.1 million, or a loss of $0.06 per share.

For the three months ended March 31, 2020, we generated cash flow from operating
activities of $17.2 million and repaid a net of $3.3 million on our
senior-secured asset-based credit facility (ABL). Due to the uncertainty from
COVID-19, as a precautionary measure we opted to hold more cash than we might
have otherwise. As of March 31, 2020, we had $12.6 million of cash and cash
equivalents, and availability under the ABL of $119.0 million, with $67.6
million of borrowings drawn under our ABL, and $19.6 million of undrawn letters
of credit outstanding, leaving $31.8 million available for borrowing.

COVID Response



Early in March, we experienced an increase in demand for crisis assignments from
our customers as a result of the COVID-19 pandemic impacting the U.S. Beginning
in March and continuing into the second quarter, we have placed more than a
thousand nurses on COVID-19 assignments with the majority going to our MSP
partners in hot spots such as New York and Washington. As these assignments
typically require higher compensation to the healthcare professionals, we have
seen higher than normal average bill rates. Since late in the first quarter, the
Company has experienced both positive and negative impacts on its business
including a significant number of crisis assignments as well as the cancellation
of non-COVID-19 assignments by

                                       20
--------------------------------------------------------------------------------

certain facilities due to low census and deferred elective procedures.
Additionally, since mid-March 2020, schools have remained closed and as a result
we are seeing a sharp decline in revenue from our education business that is
being partially offset by teletherapy services for the same clients. Overall,
demand remains volatile, as orders initially surged due to the crisis needs, and
have since trended downward as clients have reduced their contingent labor based
on their unique situations.

As part of our COVID-19 response, we established a cross-functional crisis team
with representation from all parts of our business to ensure rapid response to
our customers' needs. As a result of the mandated shelter in place orders, our
more than 1,600 employees were successfully able to work from home with minimal
disruption. Generally, travel has been suspended and we have altered the way we
communicate through the increased use of videoconferencing. Our response to this
pandemic has helped us identify better ways to execute our client-facing and
back-office operations which we expect to benefit from as we move forward.

While the impact on the first quarter was not considered significant for us,
indications are that our second quarter's results will be subject to more
volatility. Due to the uncertainty across the healthcare industry, we are unable
to predict the overall impact on our business for the second quarter. As the
country resumes normal operations as part of the phased in recovery, however, we
expect demand for these services to rebound in the second quarter. We are
proactively working with our customers to address their crisis needs, as well as
to plan for the recovery of their normal operations.

We believe our liquidity remains high as we have taken steps to preserve cash,
ending the quarter with cash of $12.6 million and $31.8 million available for
borrowing. In addition, we do not expect the future impacts of COVID-19 to have
a significant impact on our ability to maintain compliance with our financial
covenants under our revolving credit facility.

We had a very successful experience with our employees working remotely while
the shelter in place orders remain in effect with minimal disruption. We believe
the combination of the successful first quarter launch of Cross Country
Marketplace, our proprietary on-demand staffing platform, and the ability of our
employees to efficiently work remotely will allow us to greatly reduce our
office footprint throughout the country. We also remain on target for full
implementation of our applicant tracking system in the third quarter of 2020,
which we believe will create further efficiencies. Finally, we continue to
evaluate our cost structure and have taken steps in the second quarter to
realize additional cost savings through further centralization and automation
efforts.

Refer to Item 1A. Risk Factors for further discussion about potential additional risks and uncertainties.

See Results of Operations, Segment Results, and Liquidity and Capital Resources sections that follow for further information.

Operating Metrics



We evaluate our financial condition by tracking operating metrics and financial
results specific to each of our segments. Key operating metrics include hours
worked, days filled, number of FTEs, revenue per FTE, and revenue per day
filled. Other operating metrics include number of open orders, candidate
applications, contract bookings, length of assignment, bill and pay rates, and
renewal and fill rates, number of active searches, and number of placements.
These operating metrics are representative of trends that assist management in
evaluating business performance. Some of the segment financial results analyzed
include revenue, operating expenses, and contribution income. In addition, we
monitor cash flow as well as operating and leverage ratios to help us assess our
liquidity needs.

Business Segment                           Business Measurement
Nurse and Allied Staffing                  FTEs represent the average number of Nurse and
                                           Allied Staffing contract personnel on a full-time
                                           equivalent basis.
                                           Average revenue per FTE per day is calculated by
                                           dividing the Nurse and Allied Staffing revenue per
                                           FTE by the number of days worked in the respective
                                           periods. Nurse and Allied Staffing revenue also
                                           includes revenue from the permanent placement of
                                           nurses.
Physician Staffing                         Days filled is calculated by dividing the total
                                           hours invoiced during the period, including an
                                           estimate for the impact of accrued revenue, by 8
                                           hours.
                                           Revenue per day filled is calculated by dividing
                                           revenue as reported by days filled for the period
                                           presented.




                                       21

--------------------------------------------------------------------------------

Results of Operations



The following table summarizes, for the periods indicated, selected condensed
consolidated statements of operations data expressed as a percentage of revenue.
Our historical results of operations are not necessarily indicative of future
operating results.
                                                                                           Three Months Ended
                                                                                                March 31,
                                                                                       2020                   2019
Revenue from services                                                                    100.0  %               100.0  %
Direct operating expenses                                                                 76.4                   75.3
Selling, general and administrative expenses                                              21.8                   23.6
Bad debt expense                                                                           0.3                    0.1
Depreciation and amortization                                                              1.6                    1.5

Acquisition and integration-related costs                                                    -                    0.2
Restructuring costs                                                                        0.3                    0.6

Loss from operations                                                                      (0.4)                  (1.3)

Interest expense                                                                           0.4                    0.7

Loss on early extinguishment of debt                                                         -                    0.2
Other income, net                                                                            -                      -
Loss before income taxes                                                                  (0.8)                  (2.2)
Income tax expense (benefit)                                                                 -                   (1.5)

Consolidated net loss                                                                     (0.8)                  (0.7)

Less: Net income attributable to noncontrolling interest in subsidiary

                0.2                    0.2
Net loss attributable to common shareholders                                              (1.0) %                (0.9) %




                                       22

--------------------------------------------------------------------------------

Comparison of Results for the Three Months Ended March 31, 2020 compared to the Three Months Ended March 31, 2019



                                                                           Three Months Ended March 31,
                                                                                           Increase
                                                                                          (Decrease)         Increase (Decrease)
                                                       2020               2019                 $                      %
                                                                              (Amounts in thousands)
Revenue from services                              $ 210,064          $ 195,171          $   14,893                       7.6  %
Direct operating expenses                            160,461            146,917              13,544                       9.2  %
Selling, general and administrative expenses          45,881             46,036                (155)                     (0.3) %
Bad debt expense                                         539                270                 269                      99.6  %
Depreciation and amortization                          3,296              2,984                 312                      10.5  %

Acquisition and integration-related costs                 77                512                (435)                    (85.0) %
Restructuring costs                                      564              1,140                (576)                    (50.5) %

Loss from operations                                    (754)            (2,688)              1,934                      71.9  %
Interest expense                                         867              1,422                (555)                    (39.0) %

Loss on early extinguishment of debt                       -                360                (360)                   (100.0) %
Other income, net                                        (31)               (82)                 51                      62.2  %
Loss before income taxes                              (1,590)            (4,388)              2,798                      63.8  %
Income tax expense (benefit)                             178             (3,012)              3,190                     105.9  %

Consolidated net loss                                 (1,768)            (1,376)               (392)                    (28.5)
Less: Net income attributable to noncontrolling
interest in subsidiary                                   321                391                 (70)                    (17.9) %

Net loss attributable to common shareholders $ (2,089) $ (1,767) $ (322)

                    (18.2) %



Revenue from services

Revenue from services increased 7.6%, to $210.1 million for the three months
ended March 31, 2020, as compared to $195.2 million for the three months ended
March 31, 2019, reflecting higher revenue growth in all three segments. Revenue
for the three months ended March 31, 2020 was negatively impacted by COVID-19
due to suspended services resulting from school closures and, to a lesser
extent, volume declines in local staffing. See further discussion in Segment
Results.

Direct operating expenses

Direct operating expenses are comprised primarily of field employee compensation
and independent contractor expenses, housing expenses, travel expenses, and
related insurance expenses. Direct operating expenses increased $13.5 million or
9.2%, to $160.5 million for the three months ended March 31, 2020, as compared
to $146.9 million for the three months ended March 31, 2019. As a percentage of
total revenue, direct operating expenses increased to 76.4% compared to 75.3% in
the prior year period primarily due to average pay rates rising faster than bill
rates in Nurse and Allied Staffing.

Selling, general and administrative expenses



Selling, general and administrative expenses decreased 0.3%, to $45.9 million
for the three months ended March 31, 2020, as compared to $46.0 million for the
three months ended March 31, 2019. As a percentage of total revenue, selling,
general and administrative expenses decreased to 21.8% for the three months
ended March 31, 2020 as compared to 23.6% for the three months ended March 31,
2019, primarily as a result of improved operating leverage.

Depreciation and amortization expense



Depreciation and amortization expense for the three months ended March 31, 2020
increased to $3.3 million as compared to $3.0 million for the three months ended
March 31, 2019. Amortization expense increased due to accelerated amortization
of trade names in our Nurse and Allied Staffing segment, associated with our
rebranding initiatives. As a percentage of revenue,

                                       23
--------------------------------------------------------------------------------

depreciation and amortization expense was 1.6% for the three months ended March 31, 2020 and 1.5% for the three months ended March 31, 2019.

Acquisition and integration-related costs



Acquisition and integration-related costs include costs for prior acquisitions,
costs incurred for potential transactions, and accretion and valuation
adjustments on our contingent consideration liability related to the Mediscan
acquisition. In the first quarter of 2020, the final earnout amount related to
the contingent consideration was determined. See Note 7 - Debt.

Restructuring costs



Restructuring costs were primarily comprised of employee termination costs,
ongoing lease costs related to the Company's strategic reduction of its real
estate footprint, and reorganization costs as part of our planned cost savings
initiatives, and totaled $0.6 million during the three months ended March 31,
2020. During the three months ended March 31, 2019, restructuring costs totaled
$1.1 million and were primarily comprised of severance costs incurred in
connection with our cost savings initiatives.

Interest expense



Interest expense was $0.9 million for the three months ended March 31, 2020 as
compared to $1.4 million for the three months ended March 31, 2019, due to lower
average borrowings and a lower effective rate. The effective interest rate on
our borrowings was 4.4% for the three month period ended March 31, 2020 compared
to 5.8% for the three months ended March 31, 2019.

Loss on early extinguishment of debt



Loss on early extinguishment of debt was $0.4 million for the three months ended
March 31, 2019, relating to the write-off of
debt issuance costs in connection with a reduction in borrowing capacity under
the revolving credit facility, and an optional
principal prepayment of $7.5 million made on our term loan in the first quarter
of 2019. There were no similar charges for the three months ended March 31,
2020.

Income tax expense



Income tax expense was $0.2 million for the three months ended March 31, 2020,
including immaterial discrete items. For the three months ended March 31, 2019,
we recorded an income tax benefit of $3.0 million, including the impact of
discrete items, and $3.2 million excluding discrete items. As a result of the
Company's valuation allowance on substantially all of its domestic deferred tax
assets, income tax expense for the three months ended March 31, 2020 was
primarily impacted by international and state taxes. The Company did not
maintain a material valuation allowance during the three months ended March 31,
2019 and as a result, income tax expense for the three months ended March 31,
2019 was primarily impacted by the non-deductibility of certain per diem
expenses, the officers' compensation limitation, and international and state
taxes. See Note 13 - Income Taxes to our condensed consolidated financial
statements.








                                       24

--------------------------------------------------------------------------------

Segment Results

Information on operating segments and a reconciliation to (loss) income from operations for the periods indicated are as follows:


                                                  Three Months Ended
                                                      March 31,
                                                 2020             2019
                                                (amounts in thousands)
Revenue from services:
Nurse and Allied Staffing                   $   188,233       $ 175,637
Physician Staffing                               18,181          16,159
Search                                            3,650           3,375
                                            $   210,064       $ 195,171

Contribution income (loss):
Nurse and Allied Staffing                   $    14,157       $  14,296
Physician Staffing                                  631             405
Search                                             (335)           (423)
                                                 14,453          14,278

Corporate overhead                               11,270          12,330
Depreciation and amortization                     3,296           2,984

Acquisition and integration-related costs            77             512
Restructuring costs                                 564           1,140

Loss from operations                        $      (754)      $  (2,688)



In the second quarter of 2019, the Company merged its permanent search
recruitment brands. As a result, for the three months ended March 31, 2019, $0.4
million of revenue and $0.1 million of contribution income were reclassified
from Nurse and
Allied Staffing to Search to conform to the current period presentation.

Certain statistical data for our business segments for the periods indicated are
as follows:
                                                   Three Months Ended
                                              March 31,           March 31,                                   Percent
                                                2020                2019                Change                 Change

Nurse and Allied Staffing statistical data:
FTEs                                             7,145               7,017                   128                    1.8  %

Average Nurse and Allied Staffing revenue
per FTE per day                             $      290          $      278                    12                    4.3  %

Physician Staffing statistical data:
Days filled                                     10,199              10,280                   (81)                  (0.8) %
Revenue per day filled                      $    1,783          $    1,572                   211                   13.4  %


See definition of Business Measurement under the Operating Metrics section of our Management's Discussion and Analysis.












                                       25

--------------------------------------------------------------------------------

Segment Comparison - Three Months Ended March 31, 2020 compared to the Three Months Ended March 31, 2019



Nurse and Allied Staffing

Revenue from Nurse and Allied Staffing increased $12.6 million, or 7.2%, to
$188.2 million for the three months ended March 31, 2020, compared to $175.6
million for the three months ended March 31, 2019, primarily due to the
continued increase in the number of FTEs and average bill rates throughout the
quarter. Revenue for the three months ended March 31, 2020 was negatively
impacted by COVID-19 due to suspended services resulting from school closures
and, to a lesser extent, volume declines in local staffing.

Contribution income from Nurse and Allied Staffing decreased $0.1 million or
1.0%, to $14.2 million for the three months ended March 31, 2020, compared to
$14.3 million for the three months ended March 31, 2019. As a percentage of
segment revenue, contribution income margin was 7.5% for the three months ended
March 31, 2020, compared to 8.1% for the three months ended March 31, 2019.

The average number of Nurse and Allied Staffing FTEs on contract during the
three months ended March 31, 2020 increased 1.8% from the three months ended
March 31, 2019, reflecting an increase in travel nurse staffing partially offset
by local staffing. The average Nurse and Allied Staffing revenue per FTE per day
increased 4.3%, reflecting higher average bill rates related to increased
pricing.

Physician Staffing



Revenue from Physician Staffing increased $2.0 million, or 12.5%, to $18.2
million for the three months ended March 31, 2020, compared to $16.2 million for
the three months ended March 31, 2019, primarily due to higher bill rates due to
mix as well as one additional day in the quarter.

Contribution income from Physician Staffing increased $0.2 million, or 55.8% to
$0.6 million for the three months ended March 31, 2020, compared to $0.4 million
for the three months ended March 31, 2019. As a percentage of segment revenue,
contribution income was 3.5% for the three months ended March 31, 2020, compared
to 2.5% for the three months ended March 31, 2019, driven by higher revenue and
lower selling, general and administrative expenses.

Total days filled for Physician Staffing for the three months ended March 31,
2020 were 10,199 as compared with 10,280 in the prior year. Revenue per day
filled was $1,783 as compared with $1,572 in the prior year, due to a shift in
the mix of business.

Search

Revenue from Search increased $0.3 million, or 8.1%, to $3.7 million for the
three months ended March 31, 2020, compared to $3.4 million for the three months
ended March 31, 2019, due to an increase in executive search and RPO revenue,
partially offset by declines in physician search.

Contribution loss from Search was $0.3 million for the three months ended March 31, 2020, compared to contribution loss of $0.4 million for the three months ended March 31, 2019.

Corporate Overhead



Corporate overhead includes unallocated executive leadership and other
centralized corporate functional support costs such as finance, IT, legal, human
resources, and marketing, as well as public company expenses and corporate-wide
projects (initiatives). Corporate overhead decreased to $11.3 million for the
three months ended March 31, 2020, from $12.3 million for the three months ended
March 31, 2019, due to lower consulting and other professional service fees, as
well as the impact of our cost savings initiatives. As a percentage of
consolidated revenue, corporate overhead was 5.4% for the three months ended
March 31, 2020 and 6.3% for the three months ended March 31, 2019.

Transactions with Related Parties

See Note 14 - Related Party Transactions to our condensed consolidated financial statements.







                                       26

--------------------------------------------------------------------------------

Liquidity and Capital Resources



At March 31, 2020, we had $12.6 million in cash and cash equivalents and $67.6
million of borrowings drawn under our senior secured asset-based revolving
credit facility. Working capital decreased by $6.3 million to $91.6 million as
of March 31, 2020, compared to $97.9 million as of December 31, 2019. As of
March 31, 2020, our days' sales outstanding, net of amounts owed to
subcontractors, was 56 days representing a 2 day improvement from December 31,
2019.

Our operating cash flow constitutes our primary source of liquidity, and
historically, has been sufficient to fund our working capital, capital
expenditures, internal business expansion, and debt service, including our
commitments as described in the Commitments table in our Form 10-K for the year
ended December 31, 2019. Although there is uncertainty related to the
anticipated impact of COVID-19 on our future results, we expect to meet our
future needs from a combination of cash on hand, operating cash flows, and funds
available through the ABL. See debt discussion which follows.

Net cash provided by operating activities was $17.2 million in the three months ended March 31, 2020, compared to $12.8 million in the three months ended March 31, 2019, primarily due to stronger collections and the timing of disbursements.



Net cash used in investing activities was $1.0 million in the three months ended
March 31, 2020, compared to $1.2 million in the three months ended March 31,
2019. Net cash used in both periods was for capital expenditures, primarily
related to the project to replace our applicant tracking system for our travel
nurse staffing and for acquisition-related settlements in the three months ended
March 31, 2019.
Net cash used in financing activities during the three months ended March 31,
2020 was $4.6 million, compared to $9.3 million during the three months ended
March 31, 2019. During the three months ended March 31, 2020, we used cash to
repay our ABL of $3.3 million, $0.6 million for income taxes on share-based
compensation, $0.6 million for noncontrolling shareholder payments, and $0.1
million of contingent consideration. During the three months ended March 31,
2019, we used cash to make an optional principal prepayment on our term loan of
$7.5 million and paid $0.6 million in debt issuance related to an amendment to
our prior senior credit facility. We also used cash to pay $0.8 million for
income taxes on share-based compensation, $0.3 million for noncontrolling
shareholder payments, and $0.1 million of contingent consideration.

Debt

2019 ABL Credit Agreement

At March 31, 2020, availability under the ABL was $119.0 million and we had $67.6 million of borrowings drawn, as well as $19.6 million of letters of credit outstanding, leaving $31.8 million available for borrowing.



As of March 31, 2020, the interest rate spreads and fees under the Loan
Agreement were based on LIBOR plus 2.00% for the revolving portion of the
borrowing base and LIBOR plus 4.00% on the Supplemental Availability. The Base
Rate (as defined by the Loan Agreement) margins would have been 1.00% and 3.00%,
respectively, for the revolving portion and Supplemental Availability,
respectively. The LIBOR and Base Rate margins are subject to monthly pricing
adjustments, pursuant to a pricing matrix based on our excess availability under
the revolving credit facility. In addition, the facility is subject to an unused
fee, letter of credit fees, and an administrative fee. The Loan Agreement
contains various restrictions and covenants applicable to the Company and its
subsidiaries, including a covenant to maintain a minimum fixed charge coverage
ratio. We were in compliance with the fixed charge coverage ratio covenant as of
March 31, 2020.

Stockholders' Equity

See Note 12 - Stockholders' Equity to our condensed consolidated financial statements.

Commitments and Off-Balance Sheet Arrangements



As of March 31, 2020, we do not have any off-balance sheet arrangements. Our
commitments over the next five years did not change materially from December 31,
2019. See Note 12 - Contingencies to our condensed consolidated financial
statements.
Critical Accounting Policies and Estimates

Our critical accounting policies and estimates remain consistent with those reported in our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC, other than the adoption of ASU No. 2016-13, Financial Instruments -


                                       27
--------------------------------------------------------------------------------

Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments
as discussed in Note 2 - Summary of Significant Accounting Policies and Note 3 -
Customer Contracts to our condensed consolidated financial statements.

Recent Accounting Pronouncements

See Note 15 - Recent Accounting Pronouncements to our condensed consolidated financial statements.




                                       28

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses